Skip to main content
Log in

Evidence mounts against diabetes drug

  • News
  • Published:

From Nature

View current issue Submit your manuscript

Studies continue to find heart-attack risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Graham, D. J. et al. J. Am. Med. Assoc. advance online publication doi:10.1001/jama.2010.920 (2010).

  2. Nissen, S. E. & Wolski, K. N. Engl. J. Med. 356, 2457-2471 (2007).

    Article  Google Scholar 

  3. Nissen, S. E. & Wolski, K. Arch. Intern. Med. advance online publication doi:10.1001/archinternmed.2010.207 (2010).

Download references

Authors

Related links

Related links

Related external links

Avandia (rosiglitazone)

GSK clinical trial register

FDA advisory committees July 2010 joint meeting

Pharmalot

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ledford, H. Evidence mounts against diabetes drug. Nature (2010). https://doi.org/10.1038/news.2010.320

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/news.2010.320

  • Springer Nature Limited

Navigation